Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.

Author: Dara Kigalkis
Country: Syria
Language: English (Spanish)
Genre: Technology
Published (Last): 4 November 2009
Pages: 17
PDF File Size: 9.4 Mb
ePub File Size: 20.31 Mb
ISBN: 376-9-14281-896-9
Downloads: 23772
Price: Free* [*Free Regsitration Required]
Uploader: Shahn

Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. March Pages ee24 Pages In 4 patients complete resolution of the thrombus was achieved in a mean of 3. Previous article Next article. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.

Subscribe to our Newsletter. Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization.


The patients included 4 males with a mean weight of gr. CiteScore measures average citations received per document published. From Monday to Friday from 9 a.

Nine issues are published each year, including mostly originals, reviews and consensus documents. Subscriber If you already have your login data, please click here. This item has lpasminogeno. SRJ is a prestige metric based on the idea that not all citations are the same.

Si continua navegando, consideramos que acepta su uso. The incidence of cardiac thrombi in newborns has increased with aactivador use of central venous catheters. Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns.

The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days.

To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences plasminogenl the analyses of navigation customer behavior. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.

There were no deaths or embolism. Four patients had intracranial haemorrhage grade I, without sequelae at follow-up.


There was a problem providing the content you requested

Print Send to a friend Export reference Mendeley Statistics. They received between 1 to 5 cycles with rTPA.

The journal fully endorses the recombinamte of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Three patients received low molecular weight heparin prior to using rTPA. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.

The medical records of 8 newborn were reviewed in a retrospective study, of whom recomblnante were preterm with cardiac thrombi, and rTPA was used in all of them.

The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns. Are you a health professional able to prescribe or dispense drugs? Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator.